Jun 20, 2025

Featuring perspectives from Prof Nicolas Girard, Dr Jonathan Goldman, Dr Pasi A Jänne, Dr Suresh S Ramalingam, Dr Joshua K Sabari and Dr Helena Yu, moderated by Dr Yu, including the following topics:

• Introduction (0:00)
• Evolving First-Line Treatment for Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer...

Jun 19, 2025

Featuring perspectives from Dr Geoffrey Y Ku and Dr Zev Wainberg, including the following topics:

• Introduction: ASCO Preview (0:00)
• HER2-Positive Gastroesophageal Cancers (19:03)
• Immunotherapy in HER2-Negative Advanced Gastroesophageal Cancers (36:11)
• Immunotherapy in Microsatellite Instability-High Gastroesophageal...

Jun 18, 2025

Featuring perspectives from Prof Meletios-Athanasios (Thanos) C Dimopoulos and Dr Robert Z Orlowski, including the following topics:

• Introduction: ASCO 2025 Preview (0:00)
• Anti-CD38 Antibodies (10:12)
• Belantamab Mafodotin (29:45)
• CAR T-Cell Therapy (40:57)
• Bispecific Antibodies (47:33)
• Other Novel Agents (56:46)

CME...

Jun 17, 2025

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Multiple Myeloma | Faculty Presentation 2: Chimeric Antigen Receptor (CAR) T-Cell Therapy, Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) — Meletios-Athanasios (Thanos) C Dimopoulos, MD

CME information and...

Jun 17, 2025

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Multiple Myeloma | Faculty Presentation 1: Current and Emerging Therapeutic Approaches for Multiple Myeloma (MM) — Robert Z Orlowski, MD, PhD

CME information and select...